Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers August 20, 2017
Pharmacy Choice - News - Front Page Healthcare News - August 20, 2017

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

8/20/17 - Another doctor tests positive to Lassa fever in LUTH [Sun, The (Nigeria)]
?3 earlier positive doctors discharged. Chief Medical Director, Lagos University Teaching Hospital, LUTH, Idi Araba, Prof Chris Bode said, yesterday, that another doctor had tested positive to Lassa fever. Last week, two patients were brought to the Lagos University Teaching Hospital and later diagnosed with Lassa fever.
8/20/17 - KEVIN BRYANT: Culture change needed to fight opioid crisis
The opportunity to serve the Anderson community as an independent neighborhood pharmacist humbles me daily. Our access to a wide variety of medicines is the envy of most of the world, and it helps us lead happy and productive lives. But some of our loved ones succumb to a disease triggered by the very medicines that should help them.
8/20/17 - Mount Sinai partners with Contessa Health to expand hospital-level care at home program
By a News Reporter-Staff News Editor at VerticalNews Health The Mount Sinai Health System announced that it has partnered with Contessa Health, an innovative health care company that manages acute-care services at home through prospective bundled payment arrangements, to extend Mount Sinai's existing hospital-level care at home program, known as
8/20/17 - Mylan finalizes settlement over Medicaid payments for EpiPen
PITTSBURGH Generic drug giant Mylan announced Thursday it has finalized its settlement with the U.S. Department of Justice for overcharging Medicaid for the EpiPen. The settlement amount is $465 million, unchanged from when Mylan announced a preliminary deal in October that was criticized by lawmakers and others as not being harsh enough.
8/20/17 - Pharma Healthcare Newsletter - August 14 to August 18, 2017 [India Infoline News Service]
IPO Alert: Aster DM Healthcare refiles DRHP with SEBI. Aster DM Healthcare has refiled draft red herring prospectus with the market regulator, Securities and Exchange Board of India. Suven Life Sciences secures process patents in Europe, Japan and New Zealand.
8/20/17 - Recent Research from Yale University Highlight Findings in Ophthalmology (Incremental Revisions across the Life Span of Ophthalmic Devices after...
By a News Reporter-Staff News Editor at Medical Letter on the CDC& FDA Fresh data on Health and Medicine- Ophthalmology are presented in a new report. Retrospective cross-sectional analysis using publicly available FDA data. " Our news editors obtained a quote from the research from Yale University, "Ophthalmic devices initially approved via the
8/20/17 - Regional GlaxoSmithKline chief reveals how new pharma is changing Gulf health care [Arab News (Saudi Arabia)]
What the critics call big pharma has had an image problem in recent years, and Andrew Miles, the executive in charge of the global health care company GlaxoSmithKline s business in the Gulf, thinks he knows how to resolve it. Choice of medication should be a clinical choice, rather than being based on some potential conflict of interest
8/20/17 - Researchers' Work from Bioinformatics Center Focuses on Life Science Research (THPdb: Database of FDA-approved peptide and protein therapeutics)
By a News Reporter-Staff News Editor at Medical Letter on the CDC& FDA Current study results on Life Science Research have been published. According to news reporting originating from Chandigarh, India, by NewsRx correspondents, research stated, "THPdb is a manually curated repository of Food and Drug Administration approved therapeutic peptides
8/20/17 - The second-most profitable hospital in the least most-profitable state [The Hutchinson News, Kan.]
The Chartis Group's 2017 Rural Relevance study of rural hospitals rates the medical center at No. 2 in Kansas, with a 15.6 percent operating margin patient revenues minus expenses. That's one of the few bright spots for the state The Chartis Group identified with 31 rural hospitals in danger of closing. Kiowa County has the hospital that's ranked
8/20/17 - USFDA completes inspection of Laurus Labs' API facilities [India Infoline News Service]
Laurus Labs, a leading research and development driven pharmaceuticals company, announced that it has completed the US Food and Drug Administration inspection of its API facilities in Units 1 and 3 at Parawada, Visakhapatnam, Andhra Pradesh with two observation which are only procedural in nature. Laurus Labs, a leading research and development dri
8/19/17 - "Improved Factor Viii Preparations Suitable for Therapeutic Use and Processes to Obtain These" in Patent Application Approval Process (USPTO...
"Improved Factor Viii Preparations Suitable for Therapeutic Use and Processes to Obtain These" in Patent Application Approval Process. By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week A patent application by the inventors SCHMIDBAUER, Stefan; METZNER, Hubert; ROBBEL, Lars, filed on July 24, 2015, was made available online o
8/19/17 - Another Doctor Tests Positive To Lassa Fever In Lagos [Daily Independent (Nigeria)]
One new case of was identified Friday, from among the doctors that first had close contact with the index case of one of the patients who died of the disease in Lagos University Teaching Hospital, last week. Lagos has now recorded six cases of Lassa fever with this new case. Last week, Lagos reported the deaths of two patients who were brought to t
8/19/17 - AstraZeneca`s Lynparza gets additional US approval for ovarian cancer [Tehran Times (Iran)]
AstraZeneca and MSD have announced that the US Food and Drug Administration has granted approval for the PARP inhibitor, Lynparza. Sean Bohen, Executive Vice President, Global Medicines Development and Chief Medical Officer, AstraZeneca, said: Physicians have almost three years of clinical experience with Lynparza on the market and we are now pleas
8/19/17 - Attorney General Shapiro Announces Mylan Pharmaceuticals to Pay Pennsylvania $8.3 Million in Restitution Over EpiPen Scam
Pennsylvania Attorney General Josh Shapiro issued the following news release:. Attorney General Josh Shapiro announced that Pennsylvania, along with the U.S. Justice Department, has finalized a settlement with the drug manufacturer Mylan Inc., resolving claims that it overcharged taxpayers for its EpiPen emergency allergy treatment.
8/19/17 - Biocept, UT Southwestern to study liquid biopsy platform in ALK-positive non-small cell lung cancer [Sport360]
Biocept Inc. and University of Texas Southwestern Medical Center entered a clinical study agreement to evaluate the clinical utility of Biocepts Target Selector platform for patients with ALK-positive non-small cell lung cancer. We continue to evaluate our Target Selector platform in clinical studies in which the identification of ALK fusions and..
8/19/17 - Blood and Organ Bank Market Research Report by Geographical Analysis and Forecast to 2023
Transparency Market Research Report Added "Blood and Organ Bank Market" to its database.Albany, NY 08/18/2017 Blood transfusion and Organ transplant is done to save the life of an individual or to improve patient's health. According to the World Health Organization, out of 108 million blood donations done globally, 50% of the blood donations
8/19/17 - Delaware part of settlement over EpiPen charges to Medicaid
The Medicaid Fraud Control Unit of the Delaware Department of Justice will join the United States and other states to settle allegations against Mylan Inc. and its wholly-owned subsidiary over charges for its EpiPen. As part of the settlement, Delaware will receive $899,882 in restitution and other compensation. As part of the settlement, Delaware
8/19/17 - Directed Energy-Based Surgical Systems Market Global Analysis & 2024 Forecast Research Report
Albany, NY 08/18/2017 Global Directed Energy-based Surgical Systems Market: SnapshotThe global directed energy-based surgical systems market is anticipated to be encouraged by a tangible growth triggered by significant driving factors such as improvements in radiofrequency devices, surging healthcare expenditures, and increasing geriatric...
8/19/17 - FDA grants two orphan drug designations for HCC [Sudan Tribune]
The U.S. Food and Drugs Administration has granted two orphan drug designations for T cell therapy products for the treatment of hepatocellular carcinoma. The FDA Orphan drug designations are granted to drugs and biologics intended for rare diseases that affect fewer than 200,000 people in the U.S, and provides incentives that may include tax credi
8/19/17 - FDA May Limit `Risk Info` in Direct-to-Consumer TV Drug Ads [Times of Oman]
But a new approach being considered could trim those lists to feature only the most serious and potentially fatal side effects, the FDA said Friday. To come to the best solution, the FDA is asking consumers, doctors and others to comment on which risk information is most helpful in TV and other broadcast ads. Nachum Katlowitz, director of urology a
8/19/17 - Federal Contracts Awarded by Federal Agencies in Kansas (Aug. 19)
The following federal contracts were announced by federal agencies based in Kansas. LEAVENWORTH, Kan., Aug. 19 Medvet Supply LLC, Pennington, New Jersey, won a $23,316.96 federal contract modification from the U.S. Department of Veterans Affairs for medical and surgical instruments, equipment and supplies for the Chelmsford VA Consolidated Mail O
8/19/17 - Financial Alignment Initiative for Medicare-Medicaid Patients Holds Potential for Improved Outcomes
The Bipartisan Policy Center issued the following news release:. A new report released by the Bipartisan Policy Center highlights the opportunities and challenges of a federal demonstration program that seeks to better integrate care and payment structures for patients who receive both Medicare and Medicaid services. While early evaluations of the.
8/19/17 - Global and United States large Volume Infusion Pumps Market by Growth Rate, Trending Demand, Future Investments, Production Process, Service Providers, Forecast to 2022
Report studies large Volume Infusion Pumps in Global market that focuses on the top Manufacturers, Market Segment by Countries, Split by Product Types (with sales, revenue, price, market share of each type), Split by applications this report focuses ...
8/19/17 - Global CT Scanner Market Analysis and Revenue Forecast 2017-2022
The report on Global CT Scanner Market is the latest addition to the huge database of DecisionDatabases.com. This research study is segmented on the basis of applications, technology, geography, and types. The Report provides a detailed Global CT Sca...
8/19/17 - Global Magnetic Resonance Imaging Systems Market Research Report 2016-2021
The report on GlobalMagnetic Resonance Imaging Systems Marketis the latest addition to the huge database of DecisionDatabases.com. This research study is segmented on the basis of applications, technology, geography, and types. Th...
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415